Analysis of the clinicopathological characteristics, genetic phenotypes, and prognostic of pure mucinous adenocarcinoma

被引:18
作者
Chen, Zhencong [1 ]
Li, Ming [1 ]
Ma, Ke [1 ]
Shang, Guoguo [2 ]
Liang, Jiaqi [1 ]
Yin, Jiacheng [1 ]
Luo, Jizhuang [1 ]
Zhan, Cheng [1 ]
Shi, Yu [1 ]
Wang, Qun [1 ]
机构
[1] Fudan Univ, Dept Thorac, Zhongshan Hosp, Shanghai, Peoples R China
[2] Fudan Univ, Dept Pathol, Zhongshan Hosp, Shanghai, Peoples R China
基金
中国国家自然科学基金;
关键词
clinicopathological features; genetic analysis; nomogram; pure mucinous adenocarcinoma; the surveillance; epidemiology; and end results; CELL LUNG-CANCER; THYROID TRANSCRIPTION FACTOR-1; MUTATIONS; KRAS; CLASSIFICATION; EGFR; ASSOCIATION; POLYCOMB; EXPRESSION; PCGF6;
D O I
10.1002/cam4.2726
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Primary pure mucinous adenocarcinoma of the lung (PMA) is a rare subtype. However, correlations between clinicopathological features and genetic phenotypes with survival have not been described comprehensively. Methods Pure mucinous adenocarcinoma patient information collected from the Surveillance, Epidemiology, and End Results (SEER) database, the Department of Thoracic Surgery, Zhongshan Hospital, Fudan University (FDZSH), and the Cancer Genome Atlas (TCGA) were extracted, evaluated, and compared with other lung adenocarcinomas (LUAD) patient data. Gene Ontology and Kyoto Encyclopedia of Genes and Genomes pathway analyses were performed to explore the functional importance of underlying molecular changes. Overall survival (OS) was evaluated with the Kaplan-Meier method. Univariate and multivariate analysis through Cox proportional hazard regression identified risk factors that predicted OS, and the results were used to construct a nomogram to predict OS for PMA patients. Results Overall, 3622 patients, 41 patients, and 15 patients with PMA were identified from the SEER, FDZSH, and TCGA databases, respectively. There were 345 differentially expressed genes, 30 differentially mutated genes and 72 differentially methylated genes were identified between PMA and other LUAD samples. In the SEER database, PMA had a better prognosis compared to other LUAD. Compared with patients with other LUAD, patients with PMA exhibited unique clinicopathological features, including fewer grade III/IV tumors, less pleural invasion, more early-stage cancer, and more lower lobe carcinomas. Multivariate analyses showed that age, race, T stage, N stage, surgery, and chemotherapy were independent risk factors. The nomogram had a calibration index of 0.724. Conclusions Our research identified unique clinicopathological characteristics and genetic phenotypes for PMA and other LUAD. The nomogram accurately predicted OS.
引用
收藏
页码:517 / 529
页数:13
相关论文
共 34 条
[1]   Regulation of gene transcription by Polycomb proteins [J].
Aranda, Sergi ;
Mas, Gloria ;
Di Croce, Luciano .
SCIENCE ADVANCES, 2015, 1 (11)
[2]   Growth pattern-based grading of pulmonary adenocarcinoma-Analysis of 534 cases with comparison between observers and survival analysis [J].
Boland, J. M. ;
Wampfler, J. A. ;
Yang, P. ;
Yi, E. S. .
LUNG CANCER, 2017, 109 :14-20
[3]   The Transcriptional Repressor Polycomb Group Factor 6, PCGF6, Negatively Regulates Dendritic Cell Activation and Promotes Quiescence [J].
Boukhaled, Giselle M. ;
Cordeiro, Brendan ;
Deblois, Genevieve ;
Dimitrov, Vassil ;
Bailey, Swneke D. ;
Holowka, Thomas ;
Domi, Anisa ;
Guak, Hannah ;
Chiu, Huai-Hsuan Clare ;
Everts, Bart ;
Pearce, Edward J. ;
Lupien, Mathieu ;
White, John H. ;
Krawczyk, Connie M. .
CELL REPORTS, 2016, 16 (07) :1829-1837
[4]  
Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI [10.3322/caac.21492, 10.3322/caac.21609]
[5]   Pros: the present classification of mucinous adenocarcinomas of the lung [J].
Dacic, Sanja .
TRANSLATIONAL LUNG CANCER RESEARCH, 2017, 6 (02) :230-233
[6]   The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer [J].
Goldstraw, Peter ;
Chansky, Kari ;
Crowley, John ;
Rami-Porta, Ramon ;
Asamura, Hisao ;
Eberhardt, Wilfried E. E. ;
Nicholson, Andrew G. ;
Groome, Patti ;
Mitchell, Alan ;
Bolejack, Vanessa .
JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (01) :39-51
[7]   KRAS and NKX2-1 Mutations in Invasive Mucinous Adenocarcinoma of the Lung [J].
Hwang, David H. ;
Sholl, Lynette M. ;
Rojas-Rudilla, Vanesa ;
Hall, Dimity L. ;
Shivdasani, Priyanka ;
Garcia, Elizabeth R. ;
MacConaill, Laura E. ;
Vivero, Marina ;
Hornick, Jason L. ;
Kuo, Frank C. ;
Lindeman, Neal I. ;
Dong, Fei .
JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (04) :496-503
[8]   Distinct clinicopathologic characteristics of lung mucinous adenocarcinoma with KRAS mutation [J].
Ichinokawa, Hideomi ;
Ishii, Genichiro ;
Nagai, Kanji ;
Kawase, Akikazu ;
Yoshida, Junji ;
Nishimura, Mitsuyo ;
Hishida, Tomoyuki ;
Ogasawara, Naomi ;
Tsuchihara, Katsuya ;
Ochiai, Atsushi .
HUMAN PATHOLOGY, 2013, 44 (12) :2636-2642
[9]   Associations Between Mutations and Histologic Patterns of Mucin in Lung Adenocarcinoma Invasive Mucinous Pattern and Extracellular Mucin Are Associated With KRAS Mutation [J].
Kadota, Kyuichi ;
Yeh, Yi-Chen ;
D'Angelo, Sandra P. ;
Moreira, Andre L. ;
Kuk, Deborah ;
Sima, Camelia S. ;
Riely, Gregory J. ;
Arcila, Maria E. ;
Kris, Mark G. ;
Rusch, Valerie W. ;
Adusumilli, Prasad S. ;
Travis, William D. .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2014, 38 (08) :1118-1127
[10]  
Käsmann L, 2016, ANTICANCER RES, V36, P3499